Bristol-Myers Squibb
BMY
#195
Rank
HK$889.24 B
Marketcap
HK$435.46
Share price
-2.97%
Change (1 day)
14.74%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): HK$27.82

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$27.90. In 2025 the company made an earnings per share (EPS) of HK$27.11 an increase over its 2024 EPS that were of -HK$34.64.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$27.822.61%
2025HK$27.11-178.28%
2024-HK$34.64-213.92%
2023HK$30.4030.2%
2022HK$23.35-6.04%
2021HK$24.85-179.29%
2020-HK$31.35-281.37%
2019HK$17.28-27.21%
2018HK$23.74
2016HK$20.92175.26%
2015HK$7.60-19.83%
2014HK$9.48-22.44%
2013HK$12.2234.48%
2012HK$9.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.46 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.01 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.11-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.18 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.47 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.06-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$73.27 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.88-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.46 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK